Breaking News To Trading Moves

Nike beats revenue estimates, but margins and China weakness hit the stock Intro Welcome back to Breaking News to Trading Moves. Today’s headline is all about $NKE: Nike beat quarterly revenue expectations, but the market didn’t care because profitability and China trends were the real story. Let’s break down what happened and what it could mean for related US-listed stocks. What happened Nike rep...

Micron $MU surges on blowout forecast as AI-driven memory shortage tightens Today we’re talking about Micron $MU, after the company delivered a blowout forecast that sent the stock sharply higher and reignited the “memory supercycle” debate. What happened Micron issued an outsized profit outlook for its next quarter, driven by surging prices and tight supply for memory chips. The big driver is AI...

FedEx beats on earnings, lifts low-end FY profit outlook, but flags near-term air-network disruption What happened FedEx ($FDX) reported stronger-than-expected fiscal Q2 results (quarter ended November 30) and raised the low end of its full-year profit forecast. The upside was driven by higher package yields in Express and ongoing cost actions, plus wins in sectors like healthcare and automotive....

Telefónica to delist its NYSE-traded ADSs, citing costs and administrative burden Spain’s telecom giant Telefónica says it plans to voluntarily delist its American Depositary Shares from the NYSE, citing the ongoing administrative burden and costs of keeping securities listed in the US. The company doesn’t plan to move the ADSs to another US exchange. Instead, ADS holders can swap into ordinary sh...

BP’s CEO shake-up fuels “mega-merger” chatter BP just made a surprise CEO move and traders are already connecting the dots to a bigger theme: oil and gas consolidation. If BP is truly repositioning, the next 6–12 months could be about asset sales, upstream spending, and the return of “mega-merger” speculation. Reuters reports BP ($BP) is replacing CEO Murray Auchincloss, appointing Meg O’Neill (cu...

Oracle Michigan Data Center Funding Twist What happened Reuters reports Oracle’s planned $10 billion, 1+ gigawatt data centre project in Saline Township, Michigan is in flux after Blue Owl Capital did not proceed on the deal terms. Oracle says the equity-deal talks are still on schedule, but Blue Owl is not involved, and Oracle and its developer partner (Related Digital) haven’t named the new equi...

Rail Unions Oppose $85B Union Pacific–Norfolk Southern Merger, Citing Safety and Cost Risks What Happened 2 major rail unions said they oppose the proposed $85 billion merger between Union Pacific and Norfolk Southern, warning it could raise safety risks, disrupt service, and push shipping costs higher. The deal would create the 1st transcontinental railroad in the US and will face scrutiny from t...

Medline’s $6.3bn IPO becomes 2025’s biggest and signals a reopening IPO window Opening Today’s story is a big one for markets: medical supplies giant Medline has priced an upsized IPO at $29 and raised about $6.26bn–$6.3bn, set to trade on Nasdaq as $MDLN. It’s the biggest IPO of 2025 and one of the largest US listings in years, with proceeds aimed largely at reducing debt. What happened and why i...

$AMZN Targets OpenAI Deal That Could Value The AI Leader Above $500B OpenAI is reportedly in talks to raise at least $10B from Amazon and use Amazon’s Trainium AI chips, signaling a possible shift in where OpenAI buys compute and how hyperscalers compete for the biggest AI workloads. What happened and why it matters Amazon is discussing a major investment in OpenAI tied to OpenAI using AWS infrast...

US Treasury Blocks Xtellus Bid for Lukoil Foreign Assets, Deal Race Widens Quick Summary Reuters reports the US Treasury rejected a cashless, securities-swap style offer led by Xtellus Partners to buy Lukoil’s foreign assets (about $22B). The Treasury objection was that the group was not authorised to use sanctioned securities in the transaction. The rejected group is looking to escalate the decis...

UK approves GSK’s twice-yearly asthma biologic Exdensur The UK regulator (MHRA) cleared $GSK’s Exdensur as a twice-yearly, under-the-skin injection for asthma (add-on therapy for patients 12+ still uncontrolled on standard treatment) and for adults with chronic rhinosinusitis with nasal polyps. It targets IL-5 to reduce eosinophil-driven inflammation, a key driver of severe asthma flares. This is...

Nvidia Buys Slurm Developer SchedMD to Boost Open-Source AI Stack NEWS RECAP (WHAT HAPPENED) Nvidia $NVDA announced it has acquired SchedMD, the company behind Slurm, an open-source workload manager used to schedule and manage large compute jobs across clusters. Nvidia says Slurm will remain open-source and vendor-neutral, and it plans to keep investing in its development. Deal terms were not disc...

Trane ($TT) Heads Into The Open After BofA Upgrade To Buy Trane Technologies $TT heads into the U.S. open with fresh analyst optimism and a very clear AI-data-center angle: NVIDIA-linked “AI factory” thermal-management reference designs, an Amazon Grocery efficiency pilot using BrainBox AI, and a bolt-on deal for turnkey liquid-to-chip cooling (Stellar Energy Digital). Winners AI data center cooli...

Arista Networks and AI Networking Impact Today’s episode focuses on Arista Networks ($ANET) and the latest developments in AI-driven networking that could shape market sentiment. Here’s a breakdown of potential winners and losers as investors digest recent news. Winners: 1. AI Networking & Data Center Infrastructure Companies: $ANET (Arista Networks), $CSCO (Cisco Systems), $JNPR (Juniper Netw...

Deere Stock (DE) Eyes Recovery Amid Tariffs, Earnings, and 2030 Growth Targets Deere ($DE) is in focus as tariffs, earnings, and 2030 growth targets shape its outlook. We break down the winners and losers across agriculture, agtech, and industrial suppliers, highlighting key trading opportunities. Winners: 1) Agricultural Equipment Manufacturers Companies in this sector are likely to benefit from...

FDA expands BioCryst’s Orladeyo to young children The FDA approved an oral pellet version of BioCryst’s Orladeyo (berotralstat) to prevent hereditary angioedema (HAE) attacks in kids aged 2 to under 12. Orladeyo was previously approved as a once-daily capsule for ages 12+. The new “sprinkle-like” pellets can be mixed with soft food or swallowed with liquid, and BioCryst expects U.S. availability a...

Rivian stock jumps as it ditches Nvidia for a custom self-driving chip and launches cheaper paid autonomy What happened Rivian $RIVN surged after analysts praised its pivot to building a custom “Rivian Autonomy Processor” (made by TSMC) and a broader Autonomy + AI strategy, including a new paid driver-assistance package that’s priced below Tesla’s Full Self-Driving options. Why traders care Custom...

Citi starts GE Aerospace ($GE) at Buy: A&D “megatrend” trade back in focus Citi initiated coverage of GE Aerospace ($GE) with a Buy rating and a $386 price target. Citi also floated a bold bull-case: GE could become the first publicly traded aerospace & defense company to reach a $1 trillion market cap within about 5 years. The call landed with a technical tailwind too: GE popped around 4%...

Oracle’s Forecast Rekindles AI Bubble Fears What happened Oracle ($ORCL) missed quarterly expectations and issued forecasts that came in below what Wall Street wanted to see, while also signaling a bigger jump in AI-related spending (capex). That combination (weaker near-term outlook + higher spending bill) revived “AI payoff” doubts and hit risk appetite in tech. Winners - Volatility And Trading...

Broadcom Forecasts Strong Q1 Revenue on AI Chip Demand, Warns Margins Dip Broadcom said it expects a stronger-than-expected fiscal Q1 revenue as AI chip and AI networking demand stays hot, but it also guided to slightly lower margins as AI-related system sales become a bigger mix. Shares slipped in extended trading as traders weighed “bigger AI” versus “thinner margins.” Key Takeaways For Traders...

Lumexa Imaging Debuts as $LMRI: Key US Stocks Riding the Diagnostic Boom Lumexa Imaging just raised about 463 million dollars in its US IPO and will start trading on the Nasdaq under the ticker $LMRI. It is one of the largest US diagnostic imaging providers, with more than 180 centres across 13 states, and its successful deal is another sign that the IPO window for solid, cash-generating healthcar...

Cardinal Infrastructure’s Strong Nasdaq Debut Intro Today we’re looking at the Nasdaq debut of Cardinal Infrastructure Group, ticker $CDNL, and what this new IPO could mean for related US stocks – the likely winners and losers traders might want on their radar. What Happened Cardinal Infrastructure Group $CDNL, a construction and site-services company focused on wet utilities like water and sewer...

CFTC Approves Gemini Platform for Crypto Prediction Markets Gemini Space Station ($GEMI) has received a CFTC Designated Contract Market license, allowing its affiliate Gemini Titan to offer regulated prediction markets in the US. Traders will be able to buy simple yes/no event contracts on things like Bitcoin price levels and regulatory outcomes, all inside a CFTC-supervised framework. Winners Cat...

CVS Health just gave the market a fresh jolt of confidence. The company raised its 2025 profit guidance again and forecast 2026 adjusted earnings of 7.00 to 7.20 dollars per share, slightly above Wall Street expectations, driven by stronger margins at its Aetna insurance arm and its Caremark pharmacy-benefit business. It expects at least 400 billion dollars of revenue in 2026 and plans to keep tig...

ITT Prices $1.14 Billion Stock Offering To Fund SPX FLOW Deal Today we’re looking at ITT Inc.’s big capital move. The industrial tech and engineering group ITT has just priced an underwritten public offering of 7,000,000 new shares at $167 per share, with an additional 1,050,000-share greenshoe option for underwriters. The company expects around $1.14 billion in net proceeds, mainly to help fund i...